维普中文期刊产品整合服务
3475篇 您的检索式:期刊名="Mol Imaging"
    题名 作者 年代 出处 被引量
1MicroPET Imaging of Breast Cancer αv-Integrin Expression With ^84Cu-Labeled Dimeric RGD Peptides 显示文摘Chen X Y Liu S Hou Y P 2004Mol Imag Biol2004,6,5:1
2Postitron emission tomography with selected mediastinoseopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer显示文摘Yap KK Yap KS Byrne A J 2005Eur J Nucl Med Mol Imaging2005,32,9:1
3Usefulness of ^11C-mathionine PET in the evaluation of brain lesions that are hypo-or isometabolic on ^18F-FDG PET显示文摘Chung JK Kim YK Kim SK 2002Eur J Nucl Med Mol Imaging2002,29,2:1
4Assessment of cardiovascular apoptosis in the asolated rat heart by magnetic resonance molecular imaging显示文摘Hiller KH Waller C 2006Mol Imaging2006,5,:1
5Usefulness of (18 ) F-FDG PET in the post-therapy surveillance of endometrial carcinoma 显示文摘Belhocine T De Barsy C Hustinx R 2002Eur J Nucl Med Mol Imaging2002,29,9:1
6Radioguided sentinel lymph node dissection in patients with Iocalised prostate carci- noma:influence of the dose of radiolabelled colloid to avoid failure of the procedure显示文摘Brenot Rossi I Rossi D Esterni B 2008Eur J Nucl Med Mol Imaging2008,35,1:1
7Diag-nostic value of CT,PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma显示文摘Pinilla I Gómez-León N Del Campo-Del Val L 2011Q J Nucl Med Mol Imaging2011,55,5:1
8Fast and repetitive in-capillary production ofFDG显示文摘Wester H-J Schoultz B Hultsch C 2009Eur J Nucl Med Mol Imaging2009,36,4:1
9Evaluation of MS-209,a novel multidrug-resistance-reversing agent,in tumour-bearing mice by technetium-99m-MIBI imaging显示文摘Tatsumi M Tsuruo T Nishimura T 2002Eur J Nucl Med Mol Imaging2002,29,3:1
10Visualisation of Bladder Cancer Using (11)C-choline PET:First Clinical Experience显示文摘de JONG IJ PRUIM J ELSINGA PH 2002Eur J Nucl Med Mol Imaging2002,29,10:1
11Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer 显示文摘Lower V J Booya F Fletcher JG 2005Mol Imaging Biol2005,7,6:1
12Optimal left ventricu- lar lead position assessed with phase analysis on gated myocardial perfusion SPECT显示文摘Boogers MJ Chen J Van Bommel RJ 2011Eur J Nucl Med Mol Imaging2011,38,2:1
13FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma 显示文摘Yap CS Schiepers C Fishbein MC 2002Eur J Nucl Med Mol Imaging2002,29,9:1
14Magnetic resonance per- fusion imaging without contrast media 显示文摘Martirosian P Boss A Schraml C 2010Eur J Nucl Med Mol Imaging2010,37,1:1
15Radio labeled aptamers for tumourimaging and therapy 显示文摘Perkins AC Missailidis S 2007Q J Nucl Med Mol Imaging2007,51,4:1
16Characteriza- tion and evaluation of two novel fluorescent σ -2 receptor ligands as proliferation probes显示文摘Zeng C Vangveravong S Jones LA 2011Mol Imaging2011,10,6:1
17Tailoring therapy in colorectal cancer by PET-CT显示文摘Vriens D de Geus-Oei LF van der Graaf WT 2009Q J Nucl Med Mol Imaging2009,53,:1
18EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I:blood and bone marrow dosimetry in differentiated thyroid cancer therapy显示文摘Lassmann M H(a)nscheid H Chiesa C 2008Eur J Nucl Med Mol Imaging2008,35,7:1
19Antioxi-dants improve early survival of cardiomyoblasts after transplantationto the myocardium显示文摘Rodriguez-Porcel M Gheysens 0 Paulmurugan R 2010Mol Imaging Biol2010,12,3:1
20Detection of bone metastases in patients with lung cancer: 9Fc-MDP planar bone scintigraphy, 18F-fluoride PET or *SF-FDG PET/CT显示文摘Kruger S Buck AK Mottaghy FM et 01 2009Eur J Nucl Med Mol Imaging2009,36,11:1
返回顶部 每页显示:
共174页 首页 上一页 第1页 下一页 末页 /174 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费